Home > Healthcare > Medical Devices > Surgical Devices > heart lung machine market
Get a free sample of Heart-lung Machine Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Heart-lung Machine Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Some of the major companies operating in the heart-lung machine market are
These leading companies are implementing advanced technologies to cater to the large unmet needs of the consumers. These companies focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these companies are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
North America market will reach around USD 141 million by 2032, attributable to the presence of key players in the region, an increasing prevalence of cardiovascular diseases, and rising awareness regarding the benefits of heart-lung machines.
The single roller pump held a dominant market share of around 60% in 2022, owing to several clinical benefits offered by single roller pump heart-lung machine such as propelling blood through the circuit, eliminating the need for complex mechanisms.
The market size of heart-lung machine was reached USD 343 million in 2022 and will reach over USD 520 million by 2032, due to increasing prevalence of cardiovascular disorders, coupled with rising number of transplant surgeries.
Braile Biomedica, Edwards Lifesciences Corp., ELITE LIFECARE, Eurosets Srl, Getinge AB, Heart Care India Co., Hemovent GmbH, Jarvik Heart Inc., Koninklijke Philips NV, LivaNova Plc, and Medtronic Plc.